Navigation Links
Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal
Date:2/27/2008

National Foundation for Infectious Diseases Highlights Critical Need for

Improved Rates; Illustrates Best Practices

BETHESDA, Md., Feb. 27 /PRNewswire/ -- In response to recent data revealing that only 42 percent of health care personnel have received their annual influenza vaccination, the National Foundation for Infectious Diseases (NFID) has published two new reports: a Call to Action urging health care personnel to receive annual influenza vaccines and a Best Practices report illustrating innovative programs for increasing immunization rates.

These reports are part of a major initiative led by NFID to address the critical need to improve influenza vaccination rates among health care personnel. Despite many public health organizations' recommendations that health care personnel be vaccinated, the Centers for Disease Control and Prevention (CDC) data reveal that more than half do not receive their annual influenza vaccination.

"Too many valuable health care personnel risk contracting influenza because they have not been vaccinated," said William Schaffner, M.D., Vice President, NFID. "Even more troubling is the fact that these employees risk spreading the virus among the sick and often immunocompromised patients under their care. These reports, together, elevate awareness of the implications of unvaccinated health care personnel and offer health facilities innovative solutions for increasing influenza vaccination among their employees."

Call to Action Sheds Light on Vaccination Gaps

The Call to Action, "Influenza Immunization among Health Care Personnel," urges employers to dedicate adequate resources to ensure influenza immunization in the workplace. Health care personnel include all persons working in health care settings, including home health care, who have contact with patients.

Unvaccinated health facility employees can be a significant source of influenza virus transmission -- among each othe
'/>"/>

SOURCE National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
2. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season
5. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
6. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
7. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
8. AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial
9. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
10. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
11. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals ... 2a study of lonafarnib in patients with chronic ... conducted at the National Institutes of Health (NIH) ... .  The double-blinded, randomized, placebo-controlled, dose ascending study ... daily and 200 mg twice daily for 28 ...
(Date:12/22/2014)... TWi Biotechnology, Inc., today announced that ... TWi Biotechnology,s lead drug candidate, from The State ... for patent application numbered 201180018154.8.  This patent ... metabolite for treatment of type II diabetes.  The ... AC-201 for type II diabetes, and provides a ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... WIRE)--Jun 27, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ... of cell therapies, presented,poster presentations at the ... Meeting (ISSCR) in Cairns, Queensland, Australia,from June ... of the International,Society for Cellular Therapy (ISCT) ...
... IIa Clinical Trial in Type 2,Diabetes Patients ... Transition,Therapeutics Inc. ("Transition") , today announces the ... indicating that 4-weeks of,daily treatments with gastrin-based ... control parameters, including,haemoglobinA1C (HbA1c), for 6 months ...
Cached Medicine Technology:Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5
(Date:12/22/2014)... December 22, 2014 Physicians in China ... for the treatment of non-Hodgkin’s lymphoma (NHL), according to ... leading global healthcare consulting firm. MabThera is the only ... the most common form of NHL. , According to ... Barriers,” the incidence of NHL in China has been ...
(Date:12/22/2014)... 22, 2014 Explorys, the leader in ... its leadership team: Greg Yarrington as Vice President of ... Patrick Wells as Vice President of Solutions. These new ... new jobs in 2015 to support client demand for ... platform-as-a-service offerings, and growth of its partner network. ...
(Date:12/22/2014)... 2014 In recognition of Veteran’s Day, ... Hero Reward, a local organization that provides services to ... , Located on a couple hundred acres in the ... lodging, world class fishing, hunting, hiking, horseback riding, 4-wheeling, ... several years ago to support U.S. Service men and ...
(Date:12/22/2014)... New York NY (PRWEB) December 22, 2014 ... reports that a federal panel of judges has granted ... lawsuits in the U.S. District Court, Eastern District ... (JPML) issued an order on December 12 to transfer ... actions–pending in 22 districts to the Louisiana court for ...
(Date:12/22/2014)... 2014 Luxury Linen purveyor Peacock Alley ... Dallas to provide logistics and support for one of ... has a long history of giving back to the community ... this year's Toy Drive were Whataburger® and 99.5 The Wolf. ... the holidays. Providing gifts to children who would otherwise not ...
Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... Suicidal teens are not likely to get the ... team of researchers at Seattle Children,s Research Institute, the ... The study, "Adolescents With Suicidal Ideation: Health Care Use ... . The researchers found that only 13 ...
... (September 2011) Research conducted by Boston College neuroscientist Sean ... finds evidence of a new way of considering how the ... paper published in the latest issue of Nature Neuroscience ... magnetic resonance image (fMRI) to help them identify how the ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... of lymph nodes after colon cancer surgery does not seem ... Researchers from the U.S. National Cancer Institute analyzed data ... and End Results (SEER) cancer registry. The investigators found ...
... Medicine have found that thyroid-stimulating hormone (TSH), a hormone ... function in the thyroid gland, can promote bone growth ... that TSH, or drugs that mimic its affect on ... osteoporosis and other conditions involving bone loss, such as ...
... (HealthDay News) --,Statins, a widely prescribed class of drugs used ... of brain bleeds in people who,ve had strokes, new research ... an ischemic stroke, caused by blocked blood flow to the ... two previous reviews raised concerns that statins might also raise ...
... previously unrelated imaging tools into one new device, a ... the University of Southern California has proposed a new ... through minimally invasive surgery. The new technique may be ... the ovaries. Ovarian cancer has a low ...
Cached Medicine News:Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 2Health News:Study finds over 70 percent of suicidal teens don't get the mental health services they need 3Health News:Researchers utilize neuroimaging to show how brain uses objects to recognize scenes 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 2Health News:Screening Lots of Lymph Nodes Little Help for Colon Cancer Patients 3Health News:Pituitary hormone TSH found to directly influence bone growth 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2
... VenaCure Laser Vein Treatment. It is estimated ... worldwide have varicose veins. In the United States, ... of 60 suffer from painful and unsightly venous ... the capabilities of vascular therapy for the treatment ...
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
... technology provides practitioners with the ability to treat ... permanent hair reduction on all skin types and ... the practitioner to instantly switch to a 3, ... a simple twist of the handpiece dial while ...
... people are diagnosed with varicose veins every ... never seek treament and are apprehensive of ... them an effective alternative to conventional therapies., ... hook phlebectomy), is considered a laborious procedure ...
Medicine Products: